StockMacro
Menu

Leonard E Post

Insider (Form 4 reporting owner): Director CIK 1235862Name as filed: POST LEONARD EIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 28 Feb 2022, sold $1.9M in 27 sales (21 under a 10b5-1 plan set in advance) across 2 companies.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
CG Oncology CGONDirector6 Dec 202416 Nov 2026–21$1.7M
uniQure QUREDirector28 Feb 202211 Jun 2026–6$160K

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After sales+0.9 pts19 trades, 53% above the sector+51.9 pts15 trades, 67% above the sector+97.7 pts15 trades, 87% above the sector

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2026––9$1.2M-$1.2M
2025––12$580K-$580K
2024––3$75K-$75K
2023––2$51K-$51K
2022––1$13K-$13K

Every trade

27, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
16 Nov 2026CG Oncology CGONSellafter exercising options1,000$92.00$92K10b5-1 planForm 4filed 17 Nov 2026
15 Oct 2026CG Oncology CGONSellafter exercising options1,000$62.06$62K10b5-1 planForm 4filed 19 Oct 2026
15 Sep 2026CG Oncology CGONSellafter exercising options1,000$72.98$73K10b5-1 planForm 4filed 17 Sep 2026
14 Aug 2026CG Oncology CGONSellafter exercising options1,000$74.54$75K10b5-1 planForm 4filed 18 Aug 2026
15 Jul 2026CG Oncology CGONSellafter exercising options1,000$71.17$71K10b5-1 planForm 4filed 17 Jul 2026
24 Jun 2026CG Oncology CGONSellafter exercising options5,000$70.00$350K10b5-1 planForm 4filed 25 Jun 2026
22 Jun 2026CG Oncology CGONSellafter exercising options5,000$65.00$325K10b5-1 planForm 4filed 23 Jun 2026
11 Jun 2026uniQure QURESell1,993$27.06$54KNoForm 4filed 12 Jun 2026
4 Jun 2026CG Oncology CGONSellafter exercising options1,000$54.50$54K10b5-1 planForm 4filed 5 Jun 2026
17 Nov 2025CG Oncology CGONSellafter exercising options1,000$41.43$41K10b5-1 planForm 4filed 18 Nov 2025
13 Oct 2025CG Oncology CGONSellafter exercising options1,000$43.25$43K10b5-1 planForm 4filed 15 Oct 2025
30 Sep 2025CG Oncology CGONSellafter exercising options5,000$40.09$200K10b5-1 planForm 4filed 1 Oct 2025
15 Sep 2025CG Oncology CGONSellafter exercising options1,000$35.10$35K10b5-1 planForm 4filed 16 Sep 2025
3 Sep 2025CG Oncology CGONSellafter exercising options1,000$28.00$28K10b5-1 planForm 4filed 4 Sep 2025
17 Jul 2025CG Oncology CGONSellafter exercising options2,000$28.00$56K10b5-1 planForm 4filed 18 Jul 2025
20 Jun 2025uniQure QURESell2,112$14.45$31KNoForm 4filed 24 Jun 2025
21 May 2025CG Oncology CGONSellafter exercising options1,000$28.00$28K10b5-1 planForm 4filed 22 May 2025
28 Apr 2025CG Oncology CGONSellafter exercising options1,000$30.76$31K10b5-1 planForm 4filed 29 Apr 2025
17 Mar 2025CG Oncology CGONSellafter exercising options1,000$28.00$28K10b5-1 planForm 4filed 18 Mar 2025
18 Feb 2025CG Oncology CGONSellafter exercising options1,000$28.61$29K10b5-1 planForm 4filed 19 Feb 2025
13 Jan 2025CG Oncology CGONSellafter exercising options1,000$29.66$30K10b5-1 planForm 4filed 14 Jan 2025
16 Dec 2024CG Oncology CGONSellafter exercising options1,000$28.84$29K10b5-1 planForm 4filed 17 Dec 2024
6 Dec 2024CG Oncology CGONSellafter exercising options1,000$34.55$35K10b5-1 planForm 4filed 6 Dec 2024
13 Jun 2024uniQure QURESell2,222$5.14$11KNoForm 4filed 18 Jun 2024
16 Jun 2023uniQure QURESell2,291$18.83$43KNoForm 4filed 20 Jun 2023
27 Feb 2023uniQure QURESell389$19.73$8KNot statedForm 4filed 1 Mar 2023
28 Feb 2022uniQure QURESell795$16.64$13KNot statedForm 4filed 2 Mar 2022

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.